ELUSYS THERAPEUTICS INC — United States · Federal contract register · Supplier record: 8 contracts, all years ($428,151,476 · Sep 2004 – Apr 2024); $125M since January 2024 (1 contract · 1 agency); — rank in the line (of 102 suppliers · 0.0%); 2 agencies never served ($30.1M on the line without ELUSYS THERAPEUTICS INC).
Assay record ASY-US-0A1R086071 · Cite as: Assay Systems, “ELUSYS THERAPEUTICS INC in the USAspending register”, https://assay-systems.com/register/us/elusys-therapeutics-inc/
8
contracts, all years
$428,151,476 · Sep 2004 – Apr 2024
$125M
since January 2024
1 contract · 1 agency
—
rank in the line
of 102 suppliers · 0.0%
2
agencies never served
$30.1M on the line without ELUSYS THERAPEUTICS INC
Own record by year
2021 onward
$79.9M
$125M
202120222023202420252026
Who buys from ELUSYS THERAPEUTICS INC
since January 2024
1agencies
$125Mpaid
100.0%top buyer
Department of Health and Human Services100.0%
$124,523,123
Before 2024 only: Department of Defense.
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
—of 102 suppliers
$0ELUSYS THERAPEUTICS INC in the line
0.0%share of the line
Agencies that buy the line and never bought from ELUSYS THERAPEUTICS INC
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.